翔宇医疗：2026年脑机接口产品目标覆盖超千家三甲医院

Core Insights - The company, Xiangyu Medical, is focusing on non-invasive brain-computer interface (BCI) products, which have already been adopted by over 600 top-tier hospitals, with a target to exceed 1,000 by 2026, indicating accelerated commercialization and clinical implementation [1] - Xiangyu Medical has over 20 years of experience in the rehabilitation medical device industry, offering a comprehensive product range across 10 categories and over 1,000 products, addressing various clinical needs [1] - The company emphasizes the integration of BCI technology with its proprietary rehabilitation devices, ensuring compatibility and stability, which creates a competitive advantage in the market [2] Product Development and Market Strategy - Xiangyu Medical is developing a complete solution for BCI applications rather than standalone products, enhancing device compatibility and iteration speed [2] - The company is gradually advancing into the consumer market, with products aimed at health home solutions, attention and mental regulation, and travel assistance, utilizing platforms like Tmall and JD for sales [2] - The company has initiated exploration into invasive rehabilitation technologies in collaboration with Xi'an Jiaotong University, focusing on clinically validated applications that align with existing market channels [3] International Expansion - The company is targeting markets in countries involved in the Belt and Road Initiative, prioritizing products that have received FDA and CE certifications for international expansion [3] - Xiangyu Medical is exploring cross-border e-commerce for consumer-grade therapeutic devices and traditional Chinese medicine health products, while also engaging in technical exchanges with overseas manufacturers [3]